Hygieia and TempraMed Hiss Innovative Partnership
LIVONIA, Mich. – Jan. 17, 2024 – PRLog — In a groundbreaking switch, TempraMed, a prance-setter in developed temperature-based mostly entirely mostly pharmaceutical storage alternate choices, and Hygieia, a pioneer in self sustaining insulin administration, have presented a strategic partnership. This relationship brings the lowering-edge technologies of each and every companies to a worthy wider
LIVONIA, Mich. – Jan. 17, 2024 – PRLog — In a groundbreaking switch, TempraMed, a prance-setter in developed temperature-
TempraMed has been at the forefront of technological innovation with its flagship product, the VIVI Cap. This lightweight, reusable insulin pen cap represents a critical step forward in diabetes care. VIVI Cap is changing how other folks put up their diabetes medication.
Hygieia’s d-Nav® skills is the major FDA-cleared AI-pushed system that autonomously adjusts insulin doses in maintaining with the energetic wants of its particular person. This enables more frequent and optimum dose adjustments to greater put up glucose ranges. As properly as to the app which handles dosing, d-Nav customers are supported by a crew of professional clinicians who overview patient files and cease in frequent communication. This system has proven patient outcomes, with examine indicating critical reductions in A1c for patients in as early as three months.
Uniting in a dynamic partnership, Hygieia and TempraMed are put to harness their collective strengths, embarking on a mission to revolutionize diabetes administration. This collaboration is designed to empower people with diabetes, making improvements to their properly being and transforming their on each day foundation lives with ease and effectivity.
We’re incredibly wrathful to partner with Hygieia, a collaboration that marks a brand new chapter in diabetes administration,”
VIVI Cap, please focus on over with http://www.tempramed.com
Hygieia, please focus on over with
TempraMed is at the forefront of constructing and delivering groundbreaking deepest storage alternate choices for injectable medicines. Our mission is to take care of the long-standing gap within the marketplace for folks who exercise injectable medicines and gaze to embody a lifestyle marked by elevated spontaneity, convenience, and safety. TempraMed’s first launched product VIVI Cap insulin temperature defend pen cap, is scientifically validated, VIVI Cap gives 24/7/365 years of temperature protection for insulin without the necessity for any particular person intervention.
Hygieia is the developer of d-Nav®, the major FDA-cleared skills to autonomously modify insulin doses instantly to the patient. d-Nav’s AI-powered skills mechanically interprets files and independently initiates insulin administration. The d-Nav Insulin Management Program provides clinical reinforce that helps other folks with form 2 diabetes modify their insulin doses in maintaining with their physique’s changing insulin wants. Research have proven that virtually 90 p.c of americans the utilization of d-Nav represent decrease A1C in correct three months* without increasing the threat for hypoglycaemia**
* John E Schneider et al. Affect of a Fresh Insulin Management Provider on Non-insulin Pharmaceutical Costs. J Well being Econ Outcomes Res. 2018 Feb 20;6(1):fifty three-62. https://jheor.org/
** Richard M Bergenstal et al. Computerized insulin dosing guidance to optimize insulin administration in patients with form 2 diabetes: a multicenter, randomized controlled trial. Lancet 2019 Mar 16;393(10176):
